neural precursor cells derived from human embryonic stem cell line (BioMedics Japan)
Structured Review

Neural Precursor Cells Derived From Human Embryonic Stem Cell Line, supplied by BioMedics Japan, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/neural+precursor+cells+derived+from+human+embryonic+stem+cell+line/neural+precursor+cells+derived+from+human+embryonic+stem+cell+line/pmc10046908-25-45-56
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Current Advancements in Spinal Cord Injury Research—Glial Scar Formation and Neural Regeneration"
Article Title: Current Advancements in Spinal Cord Injury Research—Glial Scar Formation and Neural Regeneration
Journal: Cells
doi: 10.3390/cells12060853
Figure Legend Snippet: A list of recent clinical trials for SCI.
Techniques Used: Clinical Proteomics, Transplantation Assay, Injection, Derivative Assay, Cell Culture
Related Articles
other:Article Title: Cell transplantation to repair the injured spinal cord Article Snippet: Traumatic SCI, AIS A-D Acute, <2 weeks Phase II Safety; Sensory and motor function measured with AIS; MEP; SSEP; urine measured by ultrasound 2020–2023 45 NCT04528550 Mayo Clinic (USA) 18 y.o. and older traumatic AIS-A or B >1 year Phase II Sensory and motor function measured with AIS; SSEP; NBSS; NBD 2020–2024 40 Transplantation Assay:Article Title: Current Advancements in Spinal Cord Injury Research—Glial Scar Formation and Neural Regeneration Article Snippet: .. A Single Center, Open Label, Single Group, Phase 1/2a Clinical Study to Evaluate the Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC Derived From hESC Line in AIS-A Level of Sub-acute SCI(From 7 to 60 Days) , Derivative Assay:Article Title: Current Advancements in Spinal Cord Injury Research—Glial Scar Formation and Neural Regeneration Article Snippet: .. A Single Center, Open Label, Single Group, Phase 1/2a Clinical Study to Evaluate the Safety and Exploratory Efficacy of Transplantation Therapy Using PSA-NCAM(+) NPC Derived From hESC Line in AIS-A Level of Sub-acute SCI(From 7 to 60 Days) , Article Title: Cell transplantation to repair the injured spinal cord Article Snippet: .. S.Biomedics Co., Ltd. (Korea) , |